Chief Medical Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chief medical technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chief Medical Technology Today - Breaking & Trending Today

WIPO Publishes Aquavit's Methods for Delivering Bioactive Compositions and Formulations to the Skin

/PRNewswire/ Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery. ....

United States , David Shafer , Sobin Chang , Aquavit Pharmaceuticals Inc , Technology Officer , World Intellectual Property Organization , Aquavit Pharmaceuticals , Delivering Bioactive Compositions , Formulations Using Microchannel Delivery , European Publication Number , Chief Executive , Antigen Presenting Cells , Chief Medical Technology ,

Aquavit Further Prevails Against Counterfeiters in U.S. Following its Recent Victory in Europe

NEW YORK , March 21, 2022 /PRNewswire/ Aquavit Pharmaceuticals, Inc ( Aquavit ) continues to succeed in its intellectual property cases against. ....

New York , United States , Sobin Chang , David Shafer , Us Southern District Court , Aquavit Pharmaceuticals Inc , Eu Court , Technology Officer , Prnewswire Aquavit Pharmaceuticals Inc , European Union Intellectual Property Office , European Union , U Biomed Inc , Device Design , District Court , Judge Lehrburger , Chief Medical Technology , New Drug Applications , Biologics License Applications ,

Aquavit Further Prevails Against Counterfeiters in U.S. Following its Recent Victory in Europe

/PRNewswire/ Aquavit Pharmaceuticals, Inc ("Aquavit") continues to succeed in its intellectual property cases against counterfeiters both domestically and. ....

Sobin Chang , David Shafer , Technology Officer , European Union , European Union Intellectual Property Office , Chief Medical Technology , Aquavit Pharmaceuticals ,

Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions

Patent Granted to Aquavit for Novel RoA and MoA for Bioactive Compositions
News provided by
Share this article
Share this article
NEW YORK, May 4, 2021 /PRNewswire/ U.S. patent number 10,980,865 [Application Number 14/909,954] was granted to Aquavit Pharmaceuticals, Inc. for
direct application system and method for the delivery of bioactive compositions and formulations. The invention utilizes a repeated motion delivery technology (AQT Technology), creating a new route of administration (RoA) and mode of administration (MoA) for the pharmaceutical and biotechnology industry for the first time in decades.
“This patent combined with our recent acquisition of a License for a new botulinum toxin asset will ignite many advancements in the industry and provide limitless opportunities for New Drug Applications (NDA) or Biologics License Applications (BLA).” says Sobin Chang, MPH., CEO of Aquavit. ....

Sobin Chang , David Shafer , Aquavit Pharmaceuticals Inc , Technology Officer , New Drug Applications , Biologics License Applications , Chief Medical Technology , Sai Sankar , Chief Biomedical , Aquavit Pharmaceuticals , டேவிட் ஷாபெர் , தொழில்நுட்பம் அதிகாரி , புதியது மருந்து பயன்பாடுகள் , உயிரியல் உரிமம் பயன்பாடுகள் , சாய் சங்கர் , தலைமை உயிர் மருத்துவ ,